A
Adaptive Biotechnologies Corporation
ADPT · NASDAQ · Healthcare · 4.0B
Price · close
$25.99
+2.16% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
17.5×
Enterprise value / EBITDAEV/EBITDA
-139.2×
Free cash flow yieldFCF yield
-1.2%
Return on equityROE
-27.2%
Operating margin
-20.6%
Net debt / EBITDAbalance-sheet strength
-7.0×
Interest coverage
-4.8×
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.